Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 28 June 2011, 15:30 HKT/SGT
Share:
    

Source: Hai Kang Life Corporation Limited
Hai Kang Life's EFADchip Technology Featured in Science Magazine

HONG KONG, June 28, 2011 - (ACN Newswire) - Hai Kang Life Corporation Limited ("Hai Kang Life"), a Hong Kong-based biotechnology company founded by professor Albert Cheung-Hoi Yu, has just received significant worldwide attention by being featured in Science magazine, the leading global scientific journal.

The Friday (June 24) issue of Science contained a full page 'News Focus on Biotechnology' article on a revolutionary new lab-on-a-chip technology that is poised to change the current clinical diagnostic paradigm, and put Hong Kong firmly on the international biotech map.

The EFADchip system developed by Hai Kang Life utilizes its propertiary patented technology to detect the presence of a pathogens genetic material in a fraction of the time and with a higher precision than existing tests. This Electric Field Assisted Diagnostic (EFAD) method is also inexpensive, allowing whole at-risk populations to be screened. For example, anyone displaying flu-like symptoms can be tested for the presence of different viruses including H1N1 or SARS. Such screening would allow for accurate disease diagnosis and thus appropriate treatment could be given to patient immediately.

In addition to infectious disease diagnosis, EFADchip can also be used for cancer detection, genetic disease testing, disease surveillance and control, as well as for non-clinical applciations such as veterinary diagnostics, environmental monitoring, testing food for microbial or GMO contamination.

The new EFADchip system comprises of chip and chip-reader ("bio-reader") that can easily be deployed to rural communities where lab facilities are unavailable. In fact, they are so small they can be installed on the office desk top of any doctor. Timely deployment of these units to disease outbreak areas could prevent the development of a global pandemic. According to Zhengping Zhuang, a clinical pathologist at the U.S. National Institutes of Health, who is not connected to Hai Kang Life, the EFADchip and the bio-reader is a unique system and it gets a readout much faster than with other technologies."

Bernard Roizman, a virologist at the University of Chicago in Illinois also comments that the EFADchip system is small in size and effectively it is a lab on a chip on wheels.


Contact:
media@haikanglife.com 


Topic: Research and development
Source: Hai Kang Life Corporation Limited

Sectors: Science & Research, Daily News, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
GMG Delivers Its First Ever Bulk Shipment of THERMAL-XR(R) to Nu Calgon in the USA  
June 17, 2026 20:29 HKT/SGT
Truecaller Ads Launches 'Call-to-Cart', a New Commerce Surface Built on the Communication Layer  
June 17, 2026 18:00 HKT/SGT
Hitachi expands its work with OpenAI to accelerate AI-driven modernization and cybersecurity  
Wednesday, June 17, 2026 1:54:00 PM
Fujitsu and IBM Japan collaborate on modernization to support enterprise digital transformation  
Wednesday, June 17, 2026 1:23:00 PM
Sharp to Introduce AQUOS R11 Smartphone  
Wednesday, June 17, 2026 12:59:00 PM
Honda to Begin Supplying Three High-output Models of the eGX Electric Power Unit Series for Commercial-Grade Work Equipment  
Wednesday, June 17, 2026 12:44:00 PM
Eisai Announces Strategic Investment Supported by the UK Government's LSIMF  
Wednesday, June 17, 2026 12:28:00 PM
BAE Systems and NEC Sign MoU to Strengthen Japan's Active Cyber Defence  
Wednesday, June 17, 2026 12:10:00 PM
Anime Tokyo Station Early Summer Festival  
Wednesday, June 17, 2026 10:00:00 AM
Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix for DMX-200 in Greater China, South Korea and Southeast Asia  
June 17, 2026 09:21 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: